`

Overview

Alma Eikoh Japan Large Cap Equity is a long only fund investing in Japanese large cap stocks.
The fund is managed internally by Alma Capital London.

Share Class

NAV

Cumulative Performance (%)

Fund Inception 12 June 2014

Daily Monthly Ytd 1Yr 3Yr 5Yr Incept. Incept.Date

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance quoted. The investment return and the principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost.


Strategy & Manager

Fund Strategy

The Strategy seeks long-term capital growth by investing in Japanese large cap stocks, typically with market capitalisation in excess of US$ 1bn. The team analyses long term company fundamentals through extensive in-house bottom up research with strong risk management ethos. At the heart of the philosophy is a deep-seated knowledge and understanding of the Japanese companies that the Eikoh team invests in. Portfolio of around 30 companies which are well managed, profitable and with good prospects.


Investment Manager

Alma Capital London is an FCA-authorised fund management company, which is a subsidiary of Alma Capital Investment Management, a Luxembourg-based independent management company founded in 2006.


Key Persons

James Pulsford
Portfolio Manager
James started his career at Morgan Grenfell in 1987, moving to Japan shortly thereafter. During his 12 years in Tokyo, he went on to become the Head of the Small Cap Equity team. James returned to London in 1999 where he managed a number of Japanese large cap products for what became Deutsche Asset Management. As well as various Japanese long only mandates, James has developed the Equilibria Japan long/short strategy at this time. James now has over 35 years’ experience investing in Japan and speaks fluent Japanese. He holds a BA from Oxford University.

Tom Grew
Portfolio Manager
Tom started his career in management consulting before moving to Eikoh Research Investment Management (ERIM) in 2018, an independent asset management company led by James Pulsford established as a result of the spin out of the Japanese Equity Team from Deutsche Asset Management. At ERIM, he worked on the long-only and hedge funds management. Tom holds a BA from Cambridge University and has completed the CFA syllabus.


Statistics & Commentary

Performance

The performance data shown represents past performance. Past performance is not a guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and the principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.

Portfolio Characteristics

Top 10 Position Details

Investment Manager's Commentary

as of 28/11/2025

Market Review and Outlook

The Topix rose +1.4% in November, posting the 8th consecutive month of gains as the majority of index constituents reported first half results which were on average well received by the market. One of the major themes over the month was the reversal in share price performance of generative AI related stocks which rallied aggressively in October. Softbank Group, Advantest and others fell sharply and given their index weightings in the Nikkei, the Nikkei 225 fell 4.1% almost taking the Nikkei Topix ratio back to the level of end September. Two other major pieces of news that drove stock market performance over the month were the economic stimulus package of the new Takaiichi administration and response of China to comments made by Takaiichi regarding the defence of Taiwan. On November the 7th, Takaiichi mentioned that a hypothetical Chinese attack on Taiwan could constitute a ‘survival-threatening situation’ for Japan which would in turn justify a military intervention from the Japanese. The Chinese administration reacted strongly to this both through their rhetoric and then by advising Chinese citizens
to avoid travel to Japan as well as suspending imports of Japanese seafood products. This had a negative impact on market sentiment, especially towards more China-geared stocks. Later in the month however, there was more positive news for the market as expectations for a Fed rate cut increased and simultaneously expectations for a BOJ rate hike in December also increased which supported financial stocks. The market was also buoyed by the approval by the cabinet of the new administration’s economic package and the supplementary budget. The three main target areas of the budget are rising prices, investing for growth in the economy and strengthening Japan’s defense and diplomacy. Specific policies include raising annual income tax thresholds, scrapping provisional gasoline taxes and expansion in support for local governments and households with children. The commitment to spend 2% of GDP on defence will be brought forward from FY27 to FY25 with further growth expected over the next few years. The overall stimulus measures total Y21.3tn with Y17.7tn in spending and Y2.7tn in tax cuts. Last
year’s spending budget was Y13.9tn for context so this represents a significant expansion however the overall fiscal impact is harder to gauge due to larger than planned tax revenues and unused budget allocations. In reaction to the probability of the overall fiscal deficit widening again after several years in a row of tightening led to a weakening of the Yen and Japanese Government Bonds. The Yen finished the month at Y/$ 156.2 and the yield on the 10-year JGB hit a new high of 1.81%.

The domestic economic situation in Japan continues to remain reasonably stable with the All Japan CPI ex-Fresh Food coming in at 3.0%, in line with consensus, and the Economy Watchers Survey continuing to improve with the current conditions index at 49.1 and the future conditions index at 53.1. Machinery orders and October Industrial production numbers also improved month on month and beat expectations. The economy should see real wage growth continue in 2026 in the light of expected wage increases of around 5% for 2026, after two years of similar gain, with core inflation running smoothly at around 3%. This is allowing the Bank of Japan to continue its path to monetary policy normalisation and for companies to continue to invest for growth and pass on cost pressures. The first half results reported by Topix companies in aggregate showed net earnings growth of around +7% ex Financials and +9.4% including financials with overall company forecasts being upped by +3% on aggregate. The AI theme continues to be the major driver of market sentiment and growth for the global economy but after a very strong run so far this year, investors are re-assessing appropriate valuation levels. We continue to focus on both fundamentals and valuations and have reduced some of our exposure to this theme whilst continuing to manage a portfolio that aims to balance both defensive and cyclical stocks. The fund’s largest overweights are Tech Hardware, Financial Servies, Semiconductors and Healthcare with the largest underweights in Capital Goods, Insurance and Media.

Fund

The fund fell by -0.60% (JPY share class) in November, underperforming the Topix (dividends reinvested) by -2.03%.

Both sector allocation and stock selection negatively impacted relative fund performance in November, with stock selection accounting for the larger share at approximately 70% of the total. The fund’s overweight in Semiconductors & Semiconductor Production Equipment was the main drag on performance as the market reassessed valuations of stocks exposed to AI capital spending after the strong rally in the prior month. This also spilled over into Technology Hardware & Equipment, where the fund is overweight, particularly through component maker Ibiden, a key packaging supplier for Nvidia’s AI GPUs. This was only partly offset by the fund’s gain from its underweight in Telecommunication Services where SoftBank Group, an investor in OpenAI, also performed poorly. This environment also led to a clear outperformance of ‘value’ stocks over ‘growth’, reversing October’s pattern. Defensive names benefitted under this backdrop, leaving the overall impact to the fund broadly neutral: positive contributions from the fund’s overweights in Financial Services and Pharmaceuticals, Biotechnology & Life Sciences were offset by the underweights in Consumer Staples Distribution & Retail, Utilities, and Energy.

At the stock level, the best performer was construction company Shimizu which continued its strong performance this year; the supply demand environment domestically remains very tight, and order profitability is rising healthily. The fund’s relatively new position in KDDI outperformed after posting a solid set of first half results and a positive outlook including hopes for a turnaround in mobile ARPU which has been in decline for several years in the wake of the Suga administration’s pressure on the sector. GMO Payment Gateway, Japan’s dominant payment processing company also rose sharply after strong results and a better than expected forecast reassured the market of their growth prospects. Air-conditioner maker Daikin outperformed after its results and not owning Softbank Group helped the fund as shares retraced after a very strong October. On the other hand, Socionext fell sharply after announcing a set of results that showed weaker profitability on some of the large contracts they are working through this year and prospects for a material recovery in profitability look to be delayed beyond the next 2 to 3 years or so. Ibiden, the packaging maker geared to Nvidia which has been one of the best performing stocks in the Topix year-to-date, fell along with other AI related names and
the wafer maker Sumco also fell after guiding for a tougher environment than was expected heading into 2026. Medical data company JMDC fell though on no specific news and Kawasaki Heavy Industries was also weak after a strong run in October.

In the wake of the results announcement by Socionext, the SOC designer, we decided to sell the fund’s position. The revelation that the current book of contracts is at a lower level of profitability than expected, and that the outlook for a material improvement in margins will likely be delayed to 2028 or beyond changes our upside for the stock significantly and renders it no longer attractive. We also decided to sell the fund’s position in the pharmaceutical company Takeda and to invest the proceeds in adding to the position held in Daiichi Sankyo. Takeda’s core drug, Entyvio, is not growing quite as quickly as expected and though we remain positive on the prospects of the late-stage pipeline drugs Tak-279 and Tak-861 we don’t think the stock offers as attractive a risk reward/profile as Daiichi Sankyo. We have strong hopes for continued growth of the Enhertu franchise at Daiichi and expect the market to re-evaluate the potentially enormous market opportunity for Datroway in the coming years. We also purchased a position in the industrial conglomerate Hitachi where we think the quality and longer term outlook of the energy business remains underappreciated by the market. Hitachi’s grid business is already a global leading player and with the immense requirements for increased scale and
complexity in power grids as a result of further electrification, more renewable energy sources and now demand for AI data centres too, prospects are very bright.


Facts & Documents

Facts

Fund Domicile: Luxembourg

Fund Type: UCITS SICAV

Fund Launch: 12 June 2014

Base Currency: JPY

Depositary, Administrator, Transfert Agent: BNP Paribas SA

Dealing: Each day with 1-day notice

Cut-off time: 12 pm CET

Management Company: Alma Capital Investment Management (LU)

Investment Manager: Alma Capital Investment Management (LU)

Fund Managers: James Pulsford, Tom Grew

Countries where the fund is registered:
Luxembourg, Austria, Germany, France, UK, Italy, Switzerland, Singapore, Belgium, Ireland, Spain

Sustainability-related disclosures:
Environmental, social and governance (“ESG”) criteria have been integrated in the investment decision-making process. An ESG analysis is conducted for all target companies. This is done prior to any investment, but also on an ongoing basis. In cases where the ESG analysis process flags material sustainability risks for a particular investment, the Investment Manager will not consider making the investment, and will look to divest when such material sustainability risks arise for a particular investment. No index has been designated as a reference benchmark for this sub-fund. Further information can be found in the prospectus of the sub-fund. The extent to which the above-mentioned characteristics are met will be included in the annual report of the fund, as from the first report issued after 1 January 2022.

Identifiers:

Institutional USD Hedged Capitalisation share class
ISIN: LU1013117160   Ticker: AEJIUHA LX    Launch: 12 Jun 2014

Institutional GBP Hedged Capitalisation share class
ISIN: LU1013116949   Ticker: AEJIGHA LX    Launch: 12 Jun 2014

Institutional EUR Hedged Capitalisation share class
ISIN: LU1013116782   Ticker: AEJIEHA LX    Launch: 10 Dec 2014

Institutional JPY Capitalisation share class
ISIN: LU1013116519   Ticker: AEJPIJA LX    Launch: 10 Dec 2014

Institutional GBP Unhedged Capitalisation share class
ISIN: LU1152097108   Ticker: AEKJEGC LX    Launch: 17 Feb 2015

Institutional EUR Unhedged Distribution share class
ISIN: LU1870374920   Ticker: AEJLIED LX    Launch: 8 Mar 2019

Institutional EUR Unhedged Capitalisation share class
ISIN: LU1870374508   Ticker: AEJLIEC LX    Launch: 4 Feb 2019

Retail Clean JPY Capitalisation share class
ISIN: LU1744752707   Ticker: AEJRCJC LX    Launch: 28 Apr 2022

Retail JPY Capitalisation share class
ISIN: LU1013117327   Ticker: AEJPRJA LX    Launch: 28 Apr 2022

Documents

Subscribe to the Fund Monthly Newsletter